Insomnia drug should be classified under Schedule IV, DEA says
Drug Enforcement Administration proposes placing indiplon in Schedule IV
The Drug Enforcement Administration has proposed placing DEA proposal appeared in the Jan. 31 issue of the Federal Register.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
